Meet The Team
Rick J. Barnett
President & CEO
Mr. Barnett joined Satellite Healthcare in September 2014, bringing more than 30 years of experience at some of California's leading hospitals and ambulatory care centers. Most recently, Mr. Barnett was Sr. Vice President of VHA Inc., responsible for the enterprise on a national level, while simultaneously fulfilling his responsibilities as Executive Officer of the West Coast Region. In his roles at VHA, Mr. Barnett directed a network of more than 100 hospitals and related entities across Arizona, California, Hawaii, Nevada, Oregon, and Washington. Prior to that, Mr. Barnett served as President and CEO of Mercy Medical Center Redding; President and CEO of Mercy Medical Center Mt. Shasta; and Sr. Vice President and COO of Queen of the Valley Hospital in Napa.
As President and CEO for Satellite Healthcare, Mr. Barnett is responsible for managing the organization's strategic plans, which include further establishing Satellite Healthcare as the nation's leading not-for-profit organization dedicated to the advancement of care for people with kidney disease.
Mr. Barnett is a member of the American College of Health Care Executives, the Medical Group Management Association, the American Management Association, and the Adaptive Business Leaders Organization. He has held seats on numerous boards ranging from The Hospital Council of Northern California to various non-profit, government, and university organizations. He holds a Master’s of Business Administration from California State University at Fullerton and a Bachelor's Degree in Business Administration from Pacific Union College.
Board Chair, 2017-current
Ms. Selecky served as President, CEO, and Chairman of the board of directors of LifeMasters Supported SelfCare from 1996 until 2009. Under her leadership, the company raised more than $60 million in venture capital, grew to $130 million in annual revenues, employed more than 1,200 people in seven locations, provided care and disease management services to more than 1 million program participants nationwide, won numerous industry awards, and counted numerous health plans, employers, provider groups, labor unions, and government entities as its clients. A veteran in the field of managed health care, her career began at FHP International Corporation in the early 1980s, where she held several management positions during its rapid expansion. As president of the FHP California Health Plan, she was responsible for revenues of $2.4 billion and building a customer base of nearly one million Medicare Advantage, Medicaid, and Commercial HMO and PPO members statewide.
She currently serves on the Boards of Directors of Paris-based Teleperformance, the world’s largest publicly traded multinational customer experience and business process management outsourcer; Verity Health System, a six hospital non-profit health care system formerly operated as the Daughters of Charity system since its founding in 1858 and recapitalized by a private equity firm in 2015; and SCAN Health Plan, one of the nation’s oldest and largest not-for-profit Medicare Advantage health plans. She recently completed two terms on the national Board of Trustees for United Cerebral Palsy, a non-profit advocacy organization for people with disabilities; and serves as Strategic Advisor and Chief Commercial Officer for Ceresti Health, which is pioneering a new standard of care for Alzheimer’s Disease. She is also a Lecturer at The University of California, Irvine Paul Merage School of Business MBA program teaching Healthcare Entrepreneurship.
Mr. Panetta received his undergraduate degree and Master of Law and Taxation from Georgetown University. He has more than 20 years of experience in the exempt organization tax area. John has led the Western Area Exempt Organizations Tax Practice of an international professional services firm. He also served with the Exempt Organizations Branch of the IRS National Office. A frequent lecturer, John has served as an adjunct faculty member of the School of Taxation at Golden Gate University, and as a visiting lecturer at the Graduate School of Business at Stanford University. He is a member of the Maryland Bar Association, District of Columbia Bar Association, National Association of College and University Business Officers, and American Health Lawyers Association.
Dr. Glenn Chertow
Dr. Chertow, MD, MPH, is the Norman S. Coplon Satellite Healthcare Professor of Medicine and (by courtesy) of Health Research and Policy, and Chief, Division of Nephrology at Stanford University School of Medicine. Dr. Chertow completed his undergraduate education at University of Pennsylvania and medical education at Harvard. He completed residency in internal medicine and fellowship in nephrology at Brigham and Women’s Hospital before joining the Harvard faculty, where he remained until 1998. He then joined the faculty at University of California San Francisco, where he served as Director of Clinical Services in the Division of Nephrology and was promoted through to full Professor in the Departments of Medicine and Epidemiology and Biostatistics until joining the Stanford faculty in 2007.
Throughout his more than 20 years of experience in nephrology, Dr. Chertow has published more than 200 articles and received numerous honors and awards. In addition to an active clinical practice, administrative responsibilities, teaching and mentoring, Dr. Chertow has developed and maintained a robust clinical research program. He has served or is currently serving in leadership roles for multiple NIDDK-, NHLBI-, and VA-sponsored clinical trials, including HEMO, DAC, ATN, FHN, SPRINT, PRESERVE, ISCHEMIA, CURE-GN and TiME, and for several industry-sponsored clinical trials including TREAT, EVOLVE, BEACON, SYMPLICITY, REPRISE, CREDENCE, and DAPA-CKD. He has served in an advisory capacity to the Medicare Payment Advisory Committee and the National Quality Forum on issues related to the ESRD program, on National Institutes of Health study sections and in multiple roles with the American Society of Nephrology (ASN), including the Public Policy Board, Quality Metrics Taskforce, and as Journal of the American Society of Nephrology (JASN) Associate Editor. He is Co-Editor of Brenner and Rector’s The Kidney.
Dr. Chertow was honored by the American Kidney Fund in 2007 with the National Torchbearer Award and in 2011 with the Nephrologist of the Year Award, in recognition of his contributions to the care of persons with kidney disease. Dr. Chertow was elected to the American Society of Clinical Investigation in 2004, and in 2015, received the Belding H. Scribner Award from ASN and was elected to the Association of American Physicians and the National Academy of Medicine. In 2018, Dr. Chertow received the David M. Hume Memorial Award, the highest honor given by the National Kidney Foundation to a distinguished scientist-clinician in the field of kidney and urologic diseases.
Mr. Williams joined Stanford Health Care in January 2015 as Vice-President and General Manager of Accountable Care. He is responsible for the growth and operations of Stanford Health Care Advantage, a Medicare Advantage health plan and Stanford Health Care Alliance, an Accountable Care Organization (ACO) product offering for the self-insured employer market. He is also responsible for Affinity Medical Solutions, which manages claims payment, network and utilization management, regulatory compliance and the financial performance of Stanford Health Care product offerings and “at risk” managed care contracts.
Prior to joining Stanford Health Care, Mr. Williams successfully led the Integrated Healthcare Association (IHA), a California leadership group with balanced representation from major health plans, hospital systems, physician organizations and other healthcare stakeholders. In his role as CEO, Mr. Williams was responsible for management of a broad range of programs and initiatives, including its nationally recognized quality measurement and pay-for-performance program, value-based payment pilots, efforts to enhance the adoption of health information technology and a variety of initiatives to improve healthcare affordability. He also served as principal investigator or research associate in several IHA grant funded research studies.
Mr. Williams’ professional career includes extensive executive-level experience in medical group management, managed healthcare, and health insurance, including 15 years as a senior executive at Aetna. He served as President, West Region during his last six years at Aetna. He has led the development of many HMO and related start-ups, post-merger integration activities and served on numerous private company and non-profit boards involved in healthcare and the environment.
Mr. Williams received a bachelor of science in biology from the University of California at Santa Barbara, earned master’s degrees in business administration and public health from the University of Hawaii, and a doctoral degree in public health at the University of California at Berkeley.
Dr. Luis Alvarez
Dr. Alvarez, MD, PhD, is a nephrologist, researcher, and educator with two decades of experience in chronic kidney disease care. He currently holds the position as Chief of the Division of Nephrology at Palo Alto Medical Foundation. Additionally, he serves as Medical Director for Satellite WellBound of Fremont. Dr. Alvarez has an impressive background in medical device development and currently works on improving technologies for home hemodialysis and critical care applications.
Dr. Alvarez received his undergraduate and medical degrees from the University of California, Los Angeles, and completed his PhD in Biophysics, and nephrology clinical fellowship training at Stanford University.
Mr. Fahlman is a successful healthcare CEO with more than 30 years’ experience in executive leadership, marketing, sales, and operational management in health care services, provider and payer services, healthcare technology, eBusiness/eHealth, CRM and Internet segments. He has consistently led businesses and brands to new highs in market cap and market share.
He currently serves as Chairman of the Board for EMSI, a private equity backed leading national provider of medical information services including in-home phlebotomy and specimen collections for clinical research organizations and drug-testing for employers.
He previously was Chairman & CEO of Preferred Homecare (now part of CVS and Lincare), a leading integrated provider of home infusion pharmaceutical therapies and home medical respiratory services. Mr. Fahlman served at Arcadian Health (now Humana) as the Chairman and CEO. He also served as Chief Executive Officer of Paradigm Management Services; a healthcare management company focused primarily on case management services for catastrophic injuries, and seven years at eHealth as Chief Operating Officer and Senior Vice President.
In addition to significantly growing companies, Mr. Fahlman has experience in mergers and acquisitions and investor relations and holds a BA in Business Administration from Portland State University. Mr. Fahlman serves on the boards of several companies.
Ms. Burr is an innovation leader having most recently served as Chief Innovation Officer and Vice President of Healthcare Trend for Humana.
At Humana, Ms. Burr led the enterprise-wide innovation strategy and efforts to build new customer-centric platforms, products, and solutions to help customers engage with their health, and bend the trend on medical costs. She also founded Humana's Health Ventures group, charged with identifying, partnering and investing in the most-promising emerging companies in the healthcare space. Additionally, her diverse background includes roles at Gap, Inc., Credit Suisse First Boston, eBay and Citi.
Ms. Burr received a Bachelor of Arts in Economics from Smith College and a Masters of Business Administration from Stanford University Graduate School of Business. She served as an observer on the board of directors of two innovative, early-stage healthcare companies, Omada Health and Livongo.
Ms. Sarah Blanchard is Chief Financial Officer and Chief Operating Officer at Omada Health based in San Francisco. Omada Health works with employers and health plans to empower those living with, or at risk for, chronic conditions, such as type 2 diabetes and hypertension to change habits, improve their health and reduce healthcare spending. The chronic conditions that Omada Health addresses are direct contributors to kidney disease.
Ms. Blanchard is passionate about building excellent finance organizations for businesses that innovate and disrupt the status quo to make the world a better place. Prior to joining Omada Health, she served as Vice President of Finance for Silver Spring Networks. She has also held positions at MobiTV, Macromedia and Arthur Andersen.
Ms. Blanchard holds an MBA from University of Pennsylvania – The Wharton School and a BA in Accounting from Michigan State University.